Study of Cetuximab With Concomitant-boost Radiotherapy in Patients With Newly Diagnosed Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

NCT00865098 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Carcinoma of the Head and Neck

Interventions

DRUG: Cetuximab

Sponsor

Merck KGaA, Darmstadt, Germany